TFS Capital’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-24,060
Closed -$99K 660
2016
Q4
$99K Buy
+24,060
New +$117K 0.03% 641
2016
Q3
Sell
-10,577
Closed -$53K 743
2016
Q2
$53K Buy
+10,577
New +$46.3K 0.01% 910
2015
Q4
Sell
-28,793
Closed -$216K 746
2015
Q3
$216K Buy
+28,793
New +$210K 0.02% 724

Other funds holding ASPN

TFS Capital's ASPN Position: Q1 2017 in Review

TFS Capital sold out of Aspen Aerogels (ASPN) in Q1 2017, closing a stake of 24,060 shares — an estimated $99K sold.

TFS Capital first reported a position in ASPN in Q3 2015 and held it in 3 quarters. The position peaked at $216K in Q3 2015. 44 funds tracked by Wall St. Rank hold ASPN as of Q1 2017.

  • TFS Capital reported no remaining Aspen Aerogels position as of Q1 2017 after selling out during the quarter.
  • TFS Capital sold 24,060 Aspen Aerogels shares in Q1 2017, an estimated $99K.
  • TFS Capital first reported a position in Aspen Aerogels in Q3 2015 and held it in 3 quarters.
  • TFS Capital's Aspen Aerogels position peaked at $216K in Q3 2015.
  • 44 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2017.

Based on TFS Capital's 13F filing for Q1 2017, filed 5 May 2017.